Veracyte Inc (NASDAQ: VCYT) has reported a loss for its third fiscal quarter (ending September 30) of $-0.41 versus a loss $-0.12 for the same period a year ago. This result fell short of the consensus estimate of $-0.13 by $-0.28. For the latest four quarters through September 30, E.P.S. were $-0.69 versus $-0.61 for the same period a year ago.
Recent Price Action
Veracyte Inc (NASDAQ: VCYT) stock increased 1.3% on 11/7/23. The shares closed at $24.01. The stock has risen 18.7% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, VCYT is expected to continue to be a modest Value Eraser.
Veracyte has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Veracyte has a slightly negative Appreciation Score of 31 but a slightly positive Power Rating of 68, with the Neutral Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment